JPMorgan Chase & Co’s Viridian Therapeutics VRDN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $5.82M | Buy |
|
|||||
|
2025
Q1 | $4.02M | Sell |
|
|||||
|
2024
Q4 | $5.83M | Sell |
|
|||||
|
2024
Q3 | $9.11M | Buy |
|
|||||
|
2024
Q2 | $1.64M | Buy |
|
|||||
|
2024
Q1 | $858K | Sell |
|
|||||
|
2023
Q4 | $1.24M | Buy |
|
|||||
|
2023
Q3 | $781K | Sell |
|
|||||
|
2023
Q2 | $1.43M | Buy |
|
|||||
|
2023
Q1 | $1.26M | Sell |
|
|||||
|
2022
Q4 | $5.03M | Buy |
|
|||||
|
2022
Q3 | $1.42M | Buy |
|
|||||
|
2022
Q2 | $213K | Sell |
|
|||||
|
2022
Q1 | $345K | Buy |
|
|||||
|
2021
Q4 | $258K | Buy |
|
|||||
|
2021
Q2 | – | Sell |
|
|||||
|
2021
Q1 | $0 | Buy |
|
|||||
|
2020
Q4 | – | Sell |
|
|||||
|
2020
Q3 | $255K | Hold |
|
|||||
|
2020
Q2 | $354K | Hold |
|
|||||
|
2020
Q1 | $142K | Hold |
|
|||||
|
2019
Q4 | $153K | Hold |
|
|||||
|
2019
Q3 | $233K | Sell |
|
|||||
|
2019
Q2 | $794K | Buy |
|
|||||
|
2019
Q1 | $909K | Sell |
|
|||||
|
2018
Q4 | $1.19M | Buy |
|
|||||
|
2018
Q3 | $2.03M | Buy |
|
|||||
|
2018
Q2 | $2.28M | Buy |
|
|||||
|
2018
Q1 | $2.3M | Sell |
|
|||||
|
2017
Q4 | $3.43M | Buy |
|
|||||
|
2017
Q3 | $2.82M | Buy |
|